Haverford Trust Co Has $215.57 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Haverford Trust Co decreased its position in UnitedHealth Group Incorporated (NYSE:UNH) by 0.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 426,145 shares of the healthcare conglomerate’s stock after selling 1,280 shares during the quarter. UnitedHealth Group accounts for approximately 2.1% of Haverford Trust Co’s holdings, making the stock its 13th largest holding. Haverford Trust Co’s holdings in UnitedHealth Group were worth $215,570,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. M&T Bank Corp grew its holdings in shares of UnitedHealth Group by 13.4% in the 3rd quarter. M&T Bank Corp now owns 220,590 shares of the healthcare conglomerate’s stock valued at $128,975,000 after acquiring an additional 26,074 shares in the last quarter. Sugarloaf Wealth Management LLC lifted its stake in UnitedHealth Group by 17.6% in the 4th quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate’s stock valued at $4,025,000 after purchasing an additional 1,193 shares during the last quarter. Benjamin Edwards Inc. raised its stake in UnitedHealth Group by 1,275.3% in the third quarter. Benjamin Edwards Inc. now owns 44,547 shares of the healthcare conglomerate’s stock valued at $26,060,000 after buying an additional 41,308 shares during the period. Parsifal Capital Management LP acquired a new stake in UnitedHealth Group during the 3rd quarter valued at $21,165,000. Finally, Signal Advisors Wealth LLC raised its holdings in UnitedHealth Group by 13.0% in the 4th quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate’s stock valued at $4,611,000 after acquiring an additional 1,051 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analysts Set New Price Targets

UNH has been the topic of a number of research analyst reports. Wells Fargo & Company reduced their price target on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price on the stock in a research report on Friday, January 10th. Oppenheimer lifted their price target on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. Finally, Piper Sandler lowered their price target on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a report on Thursday, January 2nd. Twenty research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Buy” and a consensus target price of $629.32.

Insider Activity at UnitedHealth Group

In related news, Director Timothy Patrick Flynn bought 1,000 shares of the stock in a transaction that occurred on Friday, January 17th. The shares were acquired at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the purchase, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. This trade represents a 28.57 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. 0.33% of the stock is owned by corporate insiders.

UnitedHealth Group Trading Up 1.3 %

NYSE:UNH opened at $517.72 on Monday. The firm has a market cap of $473.57 billion, a price-to-earnings ratio of 33.40, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The firm has a 50-day moving average price of $510.19 and a two-hundred day moving average price of $546.71. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $5.83 EPS. On average, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were given a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 1.62%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s dividend payout ratio is presently 54.19%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.